PhoreMost and ThinkCyte partner to develop AI-based drug discovery
The partnership combines systems in order to identify subtle phenotypic changes in living cells.
MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform
MicrofluidX (MFX), a U.K. based provider of next-generation bioreactors for cell research and manufacturing, has announced £3.3 million ($4 million) of secured investments. This brings the company’s total funding to date to £7 million ($8.5 million).
Thought Machine signs Brazillian digital bank C6
C6 Bank, a full-service bank for individuals and businesses based in São Paulo, Brazil, today announces it will be using core banking technology from Thought Machine for innovative products, which will be announced shortly.
RareCan selected for Francis Crick Institute KQ Labs data-driven health accelerator programme
RareCan, the UK’s only health tech company that specialises in supporting people with rare cancers, has been selected to join the prestigious KQ Labs programme run by the world renowned Francis Crick Institute in London. KQ Labs is an accelerator programme for exciting early-stage start-ups using data as a core part of their business model to improve human health.
Nova Pangaea sets up base at Sembcorp's Wilton site
A clean technology firm has signed an agreement to base its new commercial plant and headquarters within the Teesside Freeport.
Snaile to trial end-to-end label free technology
Canada’s largest smart locker network, Snaile, has contracted Stamp Free to begin a trial of its fully end-to-end label-free technology to provide a convenient, sustainable label-free and cost-saving method of sending parcels and returns.
Thought Machine’s core banking system to “reinvent” Payset
UK-based paytech Payset is implementing a new core banking system, Vault Core, provided by fellow UK tech company Thought Machine, to underpin its international payments platform.
NHS Grampian is working with Kheiron Medical Technologies, University of Aberdeen and Microsoft to support breast cancer detection
NHS Grampian, which provides health and social care services to more than 500,000 people in Scotland, is trialling Kheiron Medical Technologies’ artificial intelligence to help medical staff detect cancer, cut the backlog of mammograms to be read and deliver results to patients faster.
Cancer patients to help trial ‘life saving’ home testing kit
Addenbrooke’s hospital is helping to trial a new home-testing device to check if cancer patients are at risk from a serious side effect of chemotherapy.
RoboK AI helps power crucial UK drones project
AI technology from Cambridge University spin-out RoboK is playing a key role in arguably the most significant drones project witnessed to date in the UK.
Teesside's Nova Pangaea Technologies secures investment from British Airways parent IAG
The clean tech firm's latest deal follows recent £5.2m investment from a group of backers
Stemnovate creates neurons from skin cells of dogs, cats and horses to reduce need for animal testing
Stemnovate has created neurons from the skin cells of dogs, cats and horses in what is thought to be a world first.
Arecor announces exclusive specialty hospital formulation collaboration
Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an exclusive formulation study collaboration with the pharmaceutical division of one of the world’s largest chemicals marketing and pharmaceuticals companies, which focuses on the development and commercialisation of speciality drugs.
Acquisition adds up for Cambridge EdTech Blutick
AQA – the UK’s leading assessment organisation – has acquired Cambridge-based AI platform Blutick which supports the teaching, learning and assessment of Key Stage 3, GCSE and A-level Maths. No figures have been released for the acquisition.
Kalium Health raises cash, moves HQ and triggers recruitment push
Cambridge University spin-out Kalium Health has lit the touchpaper to an expansion surge to advance blood monitoring technology for people living with chronic kidney and heart disease.
Rovco Partners with HOM for Wind Work Offshore Japan
UK-based Rovco and Horizon Ocean Management (HOM) have signed a memorandum of understanding (MoU) for through-life subsea asset integrity and balance of plant survey solutions for the Japanese offshore wind market.
Cambridge start-up is bought by Facebook owner as Zuckerberg pushes deeper into the metaverse
Meta has acquired a UK start-up that helps gadgets decipher sounds around them, amid Mark Zuckerberg’s efforts to revive the struggling tech giant's growth.
Arecor boosted by subsidiary’s German diabetes launch
Cambridge biopharma business Arecor Therapeutics plc saw its share price rise almost 12 per cent (25p) to 235p after European success for subsidiary Tetris Pharma.
Arecor's Tetris launches hypoglycaemia treatment in Germany
Biopharmaceutical company Arecor Therapeutics announced on Tuesday that its subsidiary Tetris Pharma has launched the ‘Ogluo’ glucagon-prefilled autoinjector pen as a treatment for severe hypoglycaemia in children and adults living with diabetes in Germany.
Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation
Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation